31,586 Shares in The Cooper Companies, Inc. (NASDAQ:COO) Bought by Aquatic Capital Management LLC

Aquatic Capital Management LLC acquired a new position in shares of The Cooper Companies, Inc. (NASDAQ:COO - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund acquired 31,586 shares of the medical device company's stock, valued at approximately $2,904,000.

A number of other institutional investors and hedge funds have also added to or reduced their stakes in COO. C2P Capital Advisory Group LLC d.b.a. Prosperity Capital Advisors acquired a new position in Cooper Companies in the 4th quarter worth $691,000. Highland Capital Management LLC acquired a new stake in Cooper Companies during the 4th quarter valued at approximately $4,004,000. Caprock Group LLC bought a new position in Cooper Companies during the 4th quarter worth approximately $282,000. Franklin Resources Inc. raised its holdings in Cooper Companies by 194.0% during the 3rd quarter. Franklin Resources Inc. now owns 48,892 shares of the medical device company's stock worth $5,265,000 after purchasing an additional 32,260 shares during the last quarter. Finally, Principal Financial Group Inc. lifted its position in shares of Cooper Companies by 6.6% in the 3rd quarter. Principal Financial Group Inc. now owns 238,305 shares of the medical device company's stock worth $26,295,000 after purchasing an additional 14,687 shares during the period. Institutional investors own 24.39% of the company's stock.

Analyst Upgrades and Downgrades

A number of equities analysts have issued reports on the company. Citigroup cut their price target on Cooper Companies from $115.00 to $110.00 and set a "buy" rating on the stock in a report on Friday, March 7th. Needham & Company LLC reaffirmed a "hold" rating on shares of Cooper Companies in a research report on Friday, March 7th. BNP Paribas raised shares of Cooper Companies to a "hold" rating in a research report on Thursday, March 13th. Stifel Nicolaus lowered their price objective on shares of Cooper Companies from $115.00 to $105.00 and set a "buy" rating on the stock in a report on Friday, March 7th. Finally, JPMorgan Chase & Co. reduced their price objective on shares of Cooper Companies from $120.00 to $110.00 and set an "overweight" rating for the company in a report on Friday, March 7th. Four equities research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $110.25.

Cooper Companies Stock Up 1.4 %

COO stock traded up $1.16 during trading on Friday, reaching $82.30. The stock had a trading volume of 1,708,554 shares, compared to its average volume of 1,429,541. The Cooper Companies, Inc. has a one year low of $69.81 and a one year high of $112.38. The company's 50 day moving average is $81.60 and its two-hundred day moving average is $92.09. The company has a quick ratio of 1.12, a current ratio of 1.91 and a debt-to-equity ratio of 0.32. The company has a market capitalization of $16.46 billion, a price-to-earnings ratio of 42.21, a P/E/G ratio of 2.25 and a beta of 1.01.

Cooper Companies (NASDAQ:COO - Get Free Report) last issued its quarterly earnings results on Thursday, March 6th. The medical device company reported $0.92 EPS for the quarter, meeting analysts' consensus estimates of $0.92. The company had revenue of $964.70 million during the quarter, compared to the consensus estimate of $981.25 million. Cooper Companies had a return on equity of 9.38% and a net margin of 10.07%. Equities research analysts forecast that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.